Expression of anoctamin 1 is associated with advanced tumor stage in patients with non-small cell lung cancer and predicts recurrence after surgery
Clinical and Translational Oncology Aug 15, 2017
He Y, et al. – The utility of Anoctamin 1 (ANO1) as a prognostic marker was gauged. An association of ANO1 overexpression and the high expression of epidermal growth factor receptor (EGFR) appeared to be a predictive marker of recurrence after surgery in non–small cell lung cancer (NSCLC) patients.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
